Education
About Us
Working with TipRanks
Follow Us
PetVivo Holdings (PETV)
OTHER OTC:PETV
PETV Stock Chart & Stats
$1.12
$0.00(0.00%)
At close: 4:00 PM EST
$1.12
$0.00(0.00%)
Day’s Range― - ―
52-Week Range$0.45 - $1.69
Previous CloseN/A
Volume249.00
Average Volume (3M)21.60K
Market Cap
$33.58M
Enterprise Value$29.66M
Total Cash (Recent Filing)$767.91K
Total Debt (Recent Filing)$86.32K
Price to Earnings (P/E)―
Beta0.09
Next Earnings
Feb 05, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.11
Shares Outstanding33,580,630
10 Day Avg. Volume14,407
30 Day Avg. Volume21,604
Financial Highlights & Ratios
PEG Ratio0.03
Price to Book (P/B)2.91
Price to Sales (P/S)10.86
P/FCF Ratio-2.09
Enterprise Value/Market Cap0.88
Enterprise Value/Revenue21.05
Enterprise Value/Gross Profit26.68
Enterprise Value/Ebitda-3.94
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
PetVivo Holdings News
PETV FAQ
What was PetVivo Holdings’s price range in the past 12 months?
PetVivo Holdings lowest stock price was $0.45 and its highest was $1.69 in the past 12 months.
What is PetVivo Holdings’s market cap?
PetVivo Holdings’s market cap is $33.58M.
When is PetVivo Holdings’s upcoming earnings report date?
PetVivo Holdings’s upcoming earnings report date is Feb 05, 2026 which is in 22 days.
How were PetVivo Holdings’s earnings last quarter?
PetVivo Holdings released its earnings results on Nov 14, 2025. The company reported -$0.114 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.114.
Is PetVivo Holdings overvalued?
According to Wall Street analysts PetVivo Holdings’s price is currently Overvalued.
Does PetVivo Holdings pay dividends?
PetVivo Holdings does not currently pay dividends.
What is PetVivo Holdings’s EPS estimate?
PetVivo Holdings’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does PetVivo Holdings have?
PetVivo Holdings has 33,580,630 shares outstanding.
What happened to PetVivo Holdings’s price movement after its last earnings report?
PetVivo Holdings reported an EPS of -$0.114 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -9.774%.
Which hedge fund is a major shareholder of PetVivo Holdings?
Currently, no hedge funds are holding shares in PETV
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
PetVivo Holdings Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
137.25%
12-Months-Change
Fundamentals
Return on Equity
-379.92%
Trailing 12-Months
Asset Growth
138.51%
Trailing 12-Months
Company Description
PetVivo Holdings
PetVivo Holdings, Inc., a biomedical device company, engages in the manufacturing, commercializing, and licensing of medical devices and biomaterials for the treatment of afflictions and diseases in animals. Its lead product is Spryng, a veterinarian-administered, intraarticular injection for the management of lameness and other joint afflictions, such as osteoarthritis in dogs and horses. The company's pipeline products also include 17 therapeutic devices for veterinary and human clinical applications. PetVivo Holdings, Inc. was founded in 2009 and is headquartered in Minneapolis, Minnesota.
PETV Earnings Call
Q2 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call highlighted significant revenue growth, international expansion, and strategic partnerships, which are positive indicators for future prospects. However, increased net loss and slow adoption in certain market segments present challenges.View all PETV earnings summariesTechnical Analysis
Iridex
―
Lifeward
―
Vivos Therapeutics
―
Allurion Technologies
―
Nexalin Technology, Inc.
―
Ownership Overview
11.47% Insiders
0.38% Other Institutional Investors
88.14% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---